Douglas, S. R., Thomas, S. M., van den Bruele, A. B., Wang, T., Parrish, K. M., Rosenberger, L. H., … Chiba, A. (2026). ASO Visual Abstract: Neoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the Covid-19 Pandemic. Ann Surg Oncol, 33(1), 173. https://doi.org/10.1245/s10434-025-18495-z

Douglas, Sasha R., Samantha M. Thomas, Astrid Botty van den Bruele, Ton Wang, Kendra M. Parrish, Laura H. Rosenberger, Jennifer K. Plichta, Maggie L. DiNome, and Akiko Chiba. “ASO Visual Abstract: Neoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the Covid-19 Pandemic.” Ann Surg Oncol 33, no. 1 (January 2026): 173. https://doi.org/10.1245/s10434-025-18495-z.

Douglas SR, Thomas SM, van den Bruele AB, Wang T, Parrish KM, Rosenberger LH, et al. ASO Visual Abstract: Neoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the Covid-19 Pandemic. Ann Surg Oncol. 2026 Jan;33(1):173.

Douglas, Sasha R., et al. “ASO Visual Abstract: Neoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the Covid-19 Pandemic.” Ann Surg Oncol, vol. 33, no. 1, Jan. 2026, p. 173. Pubmed, doi:10.1245/s10434-025-18495-z.

Douglas SR, Thomas SM, van den Bruele AB, Wang T, Parrish KM, Rosenberger LH, Plichta JK, DiNome ML, Chiba A. ASO Visual Abstract: Neoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the Covid-19 Pandemic. Ann Surg Oncol. 2026 Jan;33(1):173.